Annette Wittmann joins EMBL Australia as COO
News / 5 March 2024
Welcome to Ms Annette Wittman, who will take on the role of EMBL Australia’s Chief Operating Officer from 18 March 2024.
News / 5 March 2024
Welcome to Ms Annette Wittman, who will take on the role of EMBL Australia’s Chief Operating Officer from 18 March 2024.
News / 25 January 2024
Researchers at the EMBL Australia Single Molecule Science node at UNSW Sydney – including group leaders Yann Gambin and Richard Morris and node head Till Böcking – have cracked a mystery whose solution has long eluded researchers.
News / 22 January 2024
New insights into long-haul transport of molecular cargo in mammalian cell lines have been revealed with super-resolution microscopy in a study led by EMBL Australia group leader Dr Vaishnavi Ananthanarayanan.
News / 19 December 2023
Congratulations to EMBL Australia group leader Dr William Roman, who was awarded a $1.58 million NHMRC Investigator Grant to investigate the transcriptional repair program during muscle reconstruction.
News / 4 December 2023
We’re hiring a Chief Operating Officer to lead the EMBL Australia Secretariat & collaborate closely with the EMBL Australia Council Chair and Scientific Director.
News / 4 December 2023
EMBL Australia group leader Professor Max Cryle was part of an international team that reconstructed ancestral antibiotics to learn more about how they work in order to produce new antibiotics to combat the growing threat of antimicrobial resistance. Published in Nature Communications, this vital information will inform the development of next-generation superbug treatments.
News / 16 November 2023
EMBL Australia group leader Mikaël Martino has co-founded protein-engineering company Orio Therapeutics.
News / 3 November 2023
On a recent visit to EMBL Heidelberg, Ian Smith, Chair of the EMBL Australia Council, spoke about the synergies between EMBL and EMBL Australia, opportunities for collaboration and ideas for exciting future programs.
News / 2 November 2023
Michelle Boyle – an EMBL Australia group leader and Snow Medical Fellow based at the Burnet Institute – and Burnet Institute CEO and Director Brendan Crabb share their thoughts on the malaria vaccine newly recommended by the World Health Organisation in an article for The Conversation.
News / 30 October 2023
Keep up to date with all the latest EMBL Australia news and events.